XML 33 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Note 8- Stock-based Compensation
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

8. Stock-Based Compensation

 

2015 Equity Plan

 

The 2015 Equity Plan provides for increases to the number of shares reserved for issuance thereunder each January 1 equal to 4.0% of the total shares of the Company’s common stock outstanding as of the immediately preceding December 31, unless a lesser amount is stipulated by the Compensation Committee of the Company's board of directors. Accordingly, 81,582 shares were added to the reserve as of January 1, 2023, which shares may be issued in connection with the grant of stock-based awards, including stock options, restricted stock, restricted stock units, stock appreciation rights and other types of awards as deemed appropriate, in each case, in accordance with the terms of the 2015 Equity Plan. As of December 31, 2022, there were 24,953 shares available for future issuance under the 2015 Equity Plan.

 

 

The Company recorded stock-based compensation expense in the following expense categories of its consolidated statements of operations and comprehensive loss for the periods indicated:

 

   

December 31,

 
   

2022

   

2021

 

Research and development

  $ 215,904     $ 154,041  

General and administrative

    712,148       743,219  

Total stock-based compensation expense

  $ 928,052     $ 897,260  

 

The following table summarizes the activity related to all stock options:

 

   

Number of

Options

   

Weighted

average

exercise

price

per share

   

Weighted

average

remaining

contractual term

(in years)

   

Aggregate

Intrinsic

Value

 

Balance at January 1, 2021

    44,738     $ 407.60                  

Granted

    36,310       44.66                  

Expired

    (8,594 )     68.48                  

Balance at December 31, 2021

    72,454       265.91                  

Granted

    77,088       9.87                  

Forfeited

    (8,892 )     147.28                  

Expired

    (610 )     1,562.92                  

Outstanding at December 31, 2022

    140,040       126.75       8.5        

Exercisable at December 31, 2022

    74,086     $ 226.95       7.9        

Vested and expected to vest at December 31, 2022

    140,040     $ 126.75       8.5        

 

The weighted average grant date fair value of stock option awards granted was $9.87 and $44.66 during the years ended December 31, 2022 and 2021, respectively. The total fair value of options vested during the years ended December 31, 2022 and 2021 were $0.8 million and $0.8 million, respectively. No options were exercised during any of the periods presented. At December 31, 2022, there was $0.9 million of unrecognized compensation cost related to unvested options that will be recognized as expense over a weighted-average period of 1.5 years.

 

The grant date fair value of employee stock options is determined using the Black-Scholes Model. The following assumptions were used during the years ended December 31, 2022 and 2021:

 

    2022     2021  

Expected term (in years)

    5.5 5.7         10    

Risk-free interest rate

    1.7% 3.9%       1.3% 1.7%  

Expected volatility

    121.4% 137.1%       122.6% 125.8%  

Dividend yield

           

 

Restricted Stock Unit Awards

 

The Company issues restricted stock ("RSU") to newly elected, non-executive members of the board of directors that vest in six, tri-monthly installments beginning 18 months after the respective grant date. The fair value of an RSU is equal to the fair market value price of the Company’s common stock on the date of grant. RSU expense is recorded on a straight-line basis over the service period.

 

 

 

The following table summarizes activity related to RSU stock-based payment awards:

 

   

Number of

Units

   

Weighted

average

grant date

fair value

 

Balance at January 1, 2022

    5,509     $ 34.78  

Vested(1)

    (1,857 )     31.41  

Outstanding at December 31, 2022

    3,652       36.49  

 

(1) The RSUs vested during the year ended December 31, 2022 were settled on a hybrid basis. The Company withheld 685 shares of common stock and, in lieu of delivering such shares, paid the RSU holder an amount in cash equal to the fair market value of such shares on the vesting date, representing the holder's approximate tax liability associated with the vesting.

 

The Company recognized approximately $65,000 and $54,000 in expense related to these units during the years ended December 31, 2022 and 2021, respectively. At December 31, 2022, there was approximately $0.1 million of unrecognized compensation cost that will be recognized over a weighted average period of 1.3 years.